Skip to main content

Aberdeen Group plc

Position in PCVX — Vaxcyte, Inc.

CIK 1716774 EDINBURGH, X0

Position in PCVX

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$21,087,006
-$35,800,882 QoQ
Shares Held
362,756
-62.9% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#58
of 329 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. PCVX ranks #32 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,087,006 362,756
2026-03-31 $56,887,888 978,969
2025-12-31 $45,206,357 979,765
2025-09-30 $26,035,003 722,793
2025-06-30 $13,813,726 424,907
2025-03-31 $9,996,469 264,737
2024-12-31 $18,404,092 224,824
2024-09-30 $9,464,984 82,830
2024-06-30 $14,377,179 190,401
2024-03-31 $13,267,987 194,232
2023-12-31 $12,197,769 194,232